Skip to main content
. 2022 Nov 14;10(11):1928. doi: 10.3390/vaccines10111928

Table 4.

Awareness of HBV, HCV, and HDV infection status.

Variable Knows Infection Status of HBV Knows Infection Status of HCV Knows Infection Status of HDV
No
N (%) Row
Yes
N (%) Row
No
N (%) Row
Yes
N (%) Row
No
N (%) Row
Yes
N (%) Row
Gender
 Male 328 (67.2%) 160 (32.8%) 178 (68.7%) 81 (31.3%) 147 (99.3%) 1 (0.7%)
 Female 264 (58.5%) 187 (41.5%) 349 (60.1%) 232 (39.9%) 126 (98.4%) 2 (1.6%)
Age group
10–14 19 (100.0%) 0 (0.0%) 7 (100.0%) 0 (0.0%) 1 (100.0%) 0 (0.0%)
 15–19 13 (100.0%) 0 (0.0%) 7 (100.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
 20–24 28 (80.0%) 7 (20.0%) 11 (100.0%) 0 (0.0%) 5 (100.0%) 0 (0.0%)
 25–29 69 (53.5%) 60 (46.5%) 35 (74.5%) 12 (25.5%) 32 (97.0%) 1 (3.0%)
 30–34 113 (61.4%) 71 (38.6%) 59 (68.6%) 27 (31.4%) 52 (98.1%) 1 (1.9%)
 35–39 91 (61.1%) 58 (38.9%) 65 (61.9%) 40 (38.1%) 39 (97.5%) 1 (2.5%)
 40–44 73 (58.4%) 52 (41.6%) 67 (58.8%) 47 (41.2%) 33 (100.0%) 0 (0.0%)
 45–49 69 (67.0%) 34 (33.0%) 74 (69.2%) 33 (30.8%) 40 (100.0%) 0 (0.0%)
 50–54 61 (63.5%) 35 (36.5%) 94 (62.3%) 57 (37.7%) 40 (100.0%) 0 (0.0%)
 55–59 35 (63.6%) 20 (36.4%) 70 (56.0%) 55 (44.0%) 22 (100.0%) 0 (0.0%)
 60–64 21 (67.7%) 10 (32.3%) 38 (47.5%) 42 (52.5%) 9 (100.0%) 0 (0.0%)
Total 592 (63.0%) 347 (37.0%) 527 (62.7%) 313 (37.3%) 273 (98.9%) 3 (1.1%)